Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line - Wikidata - awgldk - TriplyDB

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

http://www.wikidata.org/entity/Q35158389

about

Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting Applications of iPSCs in Cancer Research In vitro models of cancer stem cells and clinical applications IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.Current status in cancer cell reprogramming and its clinical implications.Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies.Application of induced pluripotency in cancer studies.Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells

P2860

Q26752688-7A2C03E2-2B1F-4D5A-B6D5-14F973BD0D93 Q26798036-BC61DB57-464D-472B-8F63-2B65FD76A815 Q28076101-C679DAFA-B75A-4B5D-9DBF-680E26408F98 Q38748961-AD7F31D6-6BA8-485C-ABDE-F19E624FB98E Q38952695-4D6A18E6-CD6B-4FA7-A09B-430763AF039D Q52358133-DEA38A83-DEE9-4E80-9264-DA3E0D7212C7 Q53682453-19E35DBD-6B1D-437C-8E1D-710097A6BBE1 Q57490090-83F92B3A-DDA8-47A3-8904-9E040213C1FA

P2860

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

http://www.wikidata.org/entity/Q35158389

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@ast

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@en

type

label

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@ast

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@en

prefLabel

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@ast

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@en

P1433

Q35158389-9C64E512-2030-4AB6-8A8F-AC56A9812671

P1476

Q35158389-5D583A3D-06E2-4C41-A3FC-DC28E4FB310F

P2093

Q35158389-1547587F-C9F3-4C66-A14C-A239EB842D81

Q35158389-1A32276B-A329-4EC6-86AC-DB6EEBC502DD

Q35158389-232CDBEA-6F09-49DA-94C6-7B6E7ECD1B8D

Q35158389-29AE1FF3-B090-4590-A7D1-43C676D4D766

Q35158389-526C1D97-D40E-48B9-9A2B-739FD87EC314

Q35158389-D74B04D4-FFA9-4F7B-A84A-CAF387B291F0

Q35158389-E8E156D7-0B0C-447E-84C1-ED78ED93F1CB

Q35158389-F53FC50E-0361-44F9-8F71-8B9313611594

P2860

Q35158389-068350E0-E4B5-41C6-9DF0-5A66777A6358

Q35158389-083168E7-E2F2-4A80-B200-8CAE557DD196

Q35158389-0A467922-52ED-4B86-BCDB-82DED7CB1202

Q35158389-0BCC2502-6183-459F-8E7B-B46E960627D3

Q35158389-0CD4EEBC-D0C8-4183-877C-CDB4310332F2

Q35158389-103330B9-F199-4768-B6DE-529EA36D5AC8

Q35158389-193EA734-6740-4AC2-B879-CA96AE878E8F

Q35158389-1F29056B-FAE0-4176-A1EA-F40278F20FB2

Q35158389-28DEA858-4638-4683-AC2E-75964B68B72A

Q35158389-2D1FC599-20C5-4C7D-A31C-46430FC23B46

P304

Q35158389-C6F54712-BA12-4D90-8273-E4EC67BCE813

P31

Q35158389-D881C03C-3F46-4FD0-AC8F-D0A97F8EAEF7

P356

Q35158389-B2A89D9E-5ED7-4B1E-A948-DA6C0FDEBB48

P478

Q35158389-C1E30AEB-0BCE-41D5-9709-2B14536D6285

P577

Q35158389-898573F3-040A-4A2E-A38C-32427265584E

P5875

Q35158389-AFAAD6C9-0D72-487C-AB31-EA665A7E5F5C

P698

Q35158389-C8403EAC-499F-4EA2-8942-98D73B3E0E8B

P932

Q35158389-FABC4A28-769A-4878-AD13-2C803088C7EF

P356

FCELL.2015.00015

P1433

Frontiers in cell and developmental biology

P1476

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line

@en

P2093

David M Loeb

http://www.w3.org/2001/XMLSchema#string

David W Lee

http://www.w3.org/2001/XMLSchema#string

Joseph B Moore

http://www.w3.org/2001/XMLSchema#string

Kyung U Hong

http://www.w3.org/2001/XMLSchema#string

Michael I Barbato

http://www.w3.org/2001/XMLSchema#string

Poul H Sorensen

http://www.w3.org/2001/XMLSchema#string

Robert J Arceci

http://www.w3.org/2001/XMLSchema#string

Timothy J Triche

http://www.w3.org/2001/XMLSchema#string

P2860

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Reprogramming of human somatic cells to pluripotency with defined factors

Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines

Human induced pluripotent stem cells free of vector and transgene sequences

Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1.

Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group

Defined factors induce reprogramming of gastrointestinal cancer cells

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCELL.2015.00015

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273317258

http://www.w3.org/2001/XMLSchema#string

P698

25806369

http://www.w3.org/2001/XMLSchema#string

P932

4353378

http://www.w3.org/2001/XMLSchema#string